• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,138
109
75
71
68

COUNTRY

70
22
16
10
9

CATEGORIES

  • 574
  • 119
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,017
1,203
1,882
2,986

PUBLISHED

15
208
647
2,986

PRODUCT TYPE

2,412
494
70
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Brain Metastasis - Pipeline Review, H1 2013 Brain Metastasis - Pipeline Review, H1 2013 - Product Thumbnail Image

Brain Metastasis - Pipeline Review, H1 2013

Brain Metastasis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Brain Metastasis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Hepatic (Liver) Tumor - Pipeline Review, H1 2013 Hepatic (Liver) Tumor - Pipeline Review, H1 2013 - Product Thumbnail Image

Hepatic (Liver) Tumor - Pipeline Review, H1 2013

Hepatic (Liver) Tumor – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hepatic (Liver) Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013

Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Metastatic Brain Tumor Global Clinical Trials Review, H1, 2013" provides data on the Metastatic Brain...

February 2013
FROM
Neuroendocrine Carcinoma - Pipeline Review, H1 2013 Neuroendocrine Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuroendocrine Carcinoma - Pipeline Review, H1 2013

Neuroendocrine Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuroendocrine Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
T-Cell Leukemia - Pipeline Review, H1 2013 T-Cell Leukemia - Pipeline Review, H1 2013 - Product Thumbnail Image

T-Cell Leukemia - Pipeline Review, H1 2013

T-Cell Leukemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'T-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013 Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013

Global Markets Direct's, 'Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic...

February 2013
FROM
Fallopian Tube Cancer - Pipeline Review, H1 2013 Fallopian Tube Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H1 2013

Fallopian Tube Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Fallopian Tube Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Hodgkin Lymphoma - Pipeline Review, H1 2013 Hodgkin Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Hodgkin Lymphoma - Pipeline Review, H1 2013

Hodgkin Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hodgkin Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Rectal Cancer - Pipeline Review, H1 2013 Rectal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Rectal Cancer - Pipeline Review, H1 2013

Rectal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Rectal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
B-Cell Leukemia - Pipeline Review, H1 2013 B-Cell Leukemia - Pipeline Review, H1 2013 - Product Thumbnail Image

B-Cell Leukemia - Pipeline Review, H1 2013

B-Cell Leukemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'B-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Metastatic Liver Cancer - Pipeline Review, H1 2013 Metastatic Liver Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Review, H1 2013

Metastatic Liver Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Liver Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Lymphoma - Pipeline Review, H1 2013 Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Lymphoma - Pipeline Review, H1 2013

Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Cervical Cancer - Pipeline Review, H1 2013 Cervical Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2013

Cervical Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Anaplastic Thyroid Cancer - Pipeline Review, H1 2013 Anaplastic Thyroid Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Review, H1 2013

Anaplastic Thyroid Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Anaplastic Thyroid Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Malignant Pleural Mesothelioma - Pipeline Review, H1 2013 Malignant Pleural Mesothelioma - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Pipeline Review, H1 2013

Global Markets Direct's, 'Malignant Pleural Mesothelioma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic...

February 2013
FROM
Small-Cell Lung Cancer - Pipeline Review, H1 2013 Small-Cell Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Small-Cell Lung Cancer - Pipeline Review, H1 2013

Small-Cell Lung Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Small-Cell Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013 Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013 - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013

Gastrointestinal Stromal Tumor (GIST) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013', provides an overview of the indication’s...

February 2013
FROM
Medulloblastoma - Pipeline Review, H1 2013 Medulloblastoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Medulloblastoma - Pipeline Review, H1 2013

Medulloblastoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Medulloblastoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013

Global Markets Direct's, 'Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report...

February 2013
FROM
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 - Product Thumbnail Image

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013

Global Markets Direct's, 'Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on...

February 2013
FROM
Loading Indicator

Our Clients

Our clients' logos